Abacus Bioscience is developing a new class of immunotherapy that unleashes the power of a novel CD180 platform technology. Our Antigen-Specific Immune Accelerants (ASIA) are POTENT, SPECIFIC and DURABLE, with broad applications across infectious disease and oncology.
View Top Employees from Abacus Bioscience Inc| Website | http://www.abacusbioscience.com |
| Revenue | $1 million |
| Employees | 8 (7 on RocketReach) |
| Founded | 2017 |
| Industry | Biotechnology Research, Pharmaceuticals, Drug Discovery, Healthcare, Biotechnology |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies, SIC Code 80 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies |
Looking for a particular Abacus Bioscience Inc employee's phone or email?
Abacus Bioscience Inc Questions
The Abacus Bioscience Inc annual revenue was $1 million in 2024.
Che-Leung Law is the Chief Scientific Officer of Abacus Bioscience Inc.
7 people are employed at Abacus Bioscience Inc.
Abacus Bioscience Inc is based in Seattle, Washington.
The NAICS codes for Abacus Bioscience Inc are [32, 325, 3254].
The SIC codes for Abacus Bioscience Inc are [28, 283, 80].
Top Abacus Bioscience Inc Employees
-
31
-
34
-
5+2
-
5+5+
-
24
-
ViewEdward Clark
Chief Executive Officer at Abacus Bioscience Inc
Seattle, Washington, United States14 -
22
Related Companies
